Drug
Lanraplenib clinical trials
Also written GS-9876.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
6 studies that test it; most in 2017 (3)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2017 | 3 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Gilead Sciences (5) · Kronos Bio (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses lanraplenib is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)TerminatedPhase 1/2Kronos BioNCT05028751Written as Lanraplenib
- Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's SyndromeCompletedPhase 2Gilead SciencesNCT03100942Written as Lanraplenib
- Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)CompletedPhase 2Gilead SciencesNCT03134222Written as Lanraplenib
- Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)CompletedPhase 2Gilead SciencesNCT03285711Written as Lanraplenib
- Pharmacokinetics of Lanraplenib in Adults With Impaired Renal FunctionCompletedPhase 1Gilead SciencesNCT02959138Written as Lanraplenib.
- Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With MethotrexateCompletedPhase 2Gilead SciencesNCT02885181Written as GS-9876
Codes
What other systems call lanraplenib · ClinicalTrials.gg INT015977
- UNII (FDA) A6U64OU57ELANRAPLENIBConfirmed FDA, Wikidata
- Wikidata Q105337235lanraplenibConfirmed FDA, Wikidata
- NCI Thesaurus C174607LanraplenibOne source FDA
- DrugBank DB14770One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | A6U64OU57E | LANRAPLENIB | Confirmed FDA, Wikidata |
| Wikidata | Q105337235 | lanraplenib | Confirmed FDA, Wikidata |
| NCI Thesaurus | C174607 | Lanraplenib | One source FDA |
| DrugBank | DB14770 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.